Published online September 30, 2005
PEDIATRICS Vol. 116 No. 4 October 2005, pp. 989-995 (doi:10.1542/peds.2005-0504)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wooditch, A. C.
Right arrow Articles by Aronoff, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wooditch, A. C.
Right arrow Articles by Aronoff, S. C.
Related Collections
Right arrow Infectious Disease & Immunity
Right arrowRelated AAP Red Book topics:
Kawasaki Disease (Mucocutaneous...

REVIEW ARTICLE

Effect of Initial Corticosteroid Therapy on Coronary Artery Aneurysm Formation in Kawasaki Disease: A Meta-analysis of 862 Children

Angela C. Wooditch, MD and Stephen C. Aronoff, MD

Department of Pediatrics, Temple University School of Medicine, Philadelphia, Pennsylvania

Objective. Kawasaki disease is an acute vasculitis of infancy and childhood. When untreated, 15% to 25% of patients develop coronary artery aneurysms. Although the use of aspirin and intravenous immune globulin (IVIG) as initial therapy is well established, the role of corticosteroids is uncertain. The objective of this study was to identify clinical trials that compared the rate of coronary aneurysm formation after initial therapy with corticosteroids or an appropriate control and to determine the overall efficacy of corticosteroid therapy for the initial treatment of Kawasaki disease.

Methods. Published studies were identified by searches of the Medline and the Cochrane Central Register of Controlled Trials databases as well as hand searches of selected references. Studies were included when (1) all subjects had a stated diagnosis of Kawasaki disease; (2) a corticosteroid preparation was included as part of the initial management of the disease process; (3) a therapeutically matched control group was included for the entire study, or subsets of patients that received a therapeutic intervention identical to the experimental group except for the inclusion of a corticosteroid compound could be identified; and (4) 2-dimensional echocardiography or coronary artery catheterization was performed at least 2 weeks after therapy to detect the presence of coronary aneurysms. Included studies were evaluated for quality and heterogeneity. Meta-analysis was performed using a fixed-effects model.

Results. Eight studies fulfilled criteria for inclusion. Because 2 of these studies provided adequate detail to permit evaluation of 2 subgroups each, a total of 10 groups were available for evaluation. The significant heterogeneity that existed among the 10 studies (Q = 21.9, I2 = 59.0) was eliminated when 2 studies with markedly different study designs were removed (Q = 5.59, I2 = 0.00). Meta-analysis of the remaining 8 studies revealed a significant reduction in the incidence of coronary artery aneurysms among patients who received corticosteroid therapy plus aspirin ± IVIG compared with aspirin ± IVIG alone (odds ratio [OR] 0.546; 95% confidence interval [CI]: 0.371–0.803); the benefit of corticosteroid therapy was maintained when study subsets of aspirin alone (OR: 0.601; 95% CI: 0.392–0.921) or aspirin + IVIG (OR: 0.352; 95% CI: 0.136–0.909) were compared with matched regimens that contained corticosteroids.

Conclusion. The inclusion of corticosteroids in aspirin-containing regimens for the initial treatment of Kawasaki disease reduces the incidence of coronary aneurysms.

Key Words: Kawasaki disease • corticosteroids • coronary aneurysms • complications • therapy

Abbreviations: IVIG, intravenous immunoglobulin • OR, odds ratios • SE, standard error • CI, confidence interval

Accepted May 5, 2005.




This article has been cited by other articles:


Home page
 BMJHome page
J. P A Ioannidis, N. A Patsopoulos, and E. Evangelou
Uncertainty in heterogeneity estimates in meta-analyses
BMJ, November 3, 2007; 335(7626): 914 - 916.
[Full Text] [PDF]

Home page
 PediatricsHome page
P. F. Weiss, J. A. Feinstein, X. Luan, J. M. Burnham, and C. Feudtner
Effects of Corticosteroid on Henoch-Schonlein Purpura: A Systematic Review
Pediatrics, November 1, 2007; 120(5): 1079 - 1087.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
M. J. O'Connor and F. T. Saulsbury
Incomplete and Atypical Kawasaki Disease in a Young Infant: Severe, Recalcitrant Disease Responsive to Infliximab
Clinical Pediatrics, May 1, 2007; 46(4): 345 - 348.
[Abstract] [PDF]

Home page
 NEJMHome page
J. W. Newburger, L. A. Sleeper, B. W. McCrindle, L. L. Minich, W. Gersony, V. L. Vetter, A. M. Atz, J. S. Li, M. Takahashi, A. L. Baker, et al.
Randomized Trial of Pulsed Corticosteroid Therapy for Primary Treatment of Kawasaki Disease
N. Engl. J. Med., February 15, 2007; 356(7): 663 - 675.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
A. K. Attili and P. N. Cascade
CT and MRI of Coronary Artery Disease:Evidence-Based Review.
Am. J. Roentgenol., December 1, 2006; 187(6 Suppl): S483 - S499.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
A. K. Attili, J. M. Foral, U. J. Schoepf, P. N. Cascade, and F. S. Chew
CT and MRI of Coronary Artery Disease: Self-Assessment Module
Am. J. Roentgenol., December 1, 2006; 187(6_Supplement): S500 - S504.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
T. Kobayashi, Y. Inoue, K. Takeuchi, Y. Okada, K. Tamura, T. Tomomasa, T. Kobayashi, and A. Morikawa
Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki Disease
Circulation, June 6, 2006; 113(22): 2606 - 2612.
[Abstract] [Full Text] [PDF]

Home page
 JWatch GeneralHome page
Corticosteroids for Kawasaki Disease?
Journal Watch (General), October 25, 2005; 2005(1025): 5 - 5.
[Full Text]